Area of research
Pulmonary and Respiratory Medicine · Biomedical Engineering
Research interest
Research interests include Gastric Cancer Management and Outcomes, Bone Tissue Engineering Materials, Nanoparticle-Based Drug Delivery, and Nanoplatforms for cancer theranostics.
Pyruvate Dehydrogenase Kinase 4 Underlies the Metabolic Disorder of Cardiomyocytes in Patients With Hypertrophic Cardiomyopathy From Hypertrophy to Heart Failure.
A Heterozygous <i>Phospholamban</i> Variant (p.R14del) Leads to Left Ventricular Involvement and Heart Failure Phenotypes in Arrhythmogenic Right Ventricular Cardiomyopathy.
Heterogeneity in resilience patterns and its prediction of 1-year quality of life outcomes among patients with newly diagnosed cancer: An exploratory piecewise growth mixture model analysis
Resilience patterns and transitions in the Be Resilient To Breast Cancer trial: an exploratory latent profile transition analysis
Intraperitoneal Chemotherapy Using Fluorouracil Implants Combined With Radical Resection and Postoperative Adjuvant Chemotherapy for Stage III Gastric Cancer: A Multi-Center, Randomized, Open-Label, Controlled Clinical Study
Nano-immunotherapy: Unique mechanisms of nanomaterials in synergizing cancer immunotherapy
Preparation of Strong Antioxidative, Therapeutic Nanoparticles Based on Amino Acid-Induced Ultrafast Assembly of Tea Polyphenols.
General Nanomedicine Platform by Solvent-Mediated Disassembly/Reassembly of Scalable Natural Polyphenol Colloidal Spheres.
Treatment Decision Making and Regret in Parents of Children With Incurable Cancer
A biopsychosocial model of resilience for breast cancer: A preliminary study in mainland China
Validation of clinical significance of examined lymph node count for accurate prognostic evaluation of gastric cancer for the eighth edition of the American Joint Committee on Cancer (AJCC) TNM staging system
Symptoms and management of children with incurable cancer in mainland China
Effect of a mentor-based, supportive-expressive program, Be Resilient to Breast Cancer, on survival in metastatic breast cancer: a randomised, controlled intervention trial